Point-Counterpoint: The Hope-Simpson Hypothesis and Its Implications Regarding an Effect of Routine Varicella Vaccination on Herpes Zoster Incidence
- PMID: 30247602
- DOI: 10.1093/infdis/jiy418
Point-Counterpoint: The Hope-Simpson Hypothesis and Its Implications Regarding an Effect of Routine Varicella Vaccination on Herpes Zoster Incidence
Abstract
Some 50 years ago, Edgar Hope-Simpson published his hypothesis regarding the interactions between varicella and herpes zoster. As part of this hypothesis, Hope-Simpson postulated that reactivation of varicella zoster virus (VZV) was under immunological control, and that this immunological control could be boosted "endogenously" due to reactivation of latent VZV, and "exogenously" due to exposure to varicella. This hypothesis has important policy implications and remains a source of debate today; namely, does reducing VZV circulation through effective pediatric varicella vaccination programs lead to unintended increases in herpes zoster (HZ) incidence? This article provides 2 very different perspectives on this issue. The first perspective (Rafael Harpaz: Evidence Against an Effect) highlights the empiric experience of the United States, with its population of >300 million, a highly effective national varicella vaccination program lasting >20 years, and with several credible sources of data regarding HZ incidence. The US data have shown an increase in HZ incidence that preceded the availability of varicella vaccination by decades; indeed, HZ rates appear to have plateaued among older adults since varicella vaccination was introduced. Furthermore, HZ rates are not different in states having higher vs lower preschool varicella vaccination rates. The second perspective (Albert J. van Hoek: Evidence for an Effect) cites data that persons with close exposure to children appear to be at lower risk of HZ before universal VZV vaccination, but not so thereafter. Due to historic demographic changes, exogenous boosting could play a role in explaining the observed increase in HZ before varicella vaccination. Thus, it might be difficult to separate declines in exogenous boosting due to demographic changes from those caused by the varicella vaccination program. Additional data will be needed to conclusively rule out an impact of varicella vaccination on HZ.
Comment in
-
Advances and Controversies in Our Understanding of Herpes Zoster-Introduction.J Infect Dis. 2018 Sep 22;218(suppl_2):S55-S56. doi: 10.1093/infdis/jiy156. J Infect Dis. 2018. PMID: 30247594 No abstract available.
-
Reply to Finn.J Infect Dis. 2019 Apr 19;219(10):1681-1682. doi: 10.1093/infdis/jiy643. J Infect Dis. 2019. PMID: 30445470 No abstract available.
-
The Hope-Simpson Hypothesis, Varicella Vaccination and Herpes Zoster Control.J Infect Dis. 2019 Apr 19;219(10):1681. doi: 10.1093/infdis/jiy642. J Infect Dis. 2019. PMID: 30445478 No abstract available.
Similar articles
-
Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.Vaccine. 2018 Feb 14;36(8):1116-1125. doi: 10.1016/j.vaccine.2018.01.038. Epub 2018 Jan 20. Vaccine. 2018. PMID: 29366704
-
Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.Hum Vaccin Immunother. 2016 Jul 2;12(7):1766-76. doi: 10.1080/21645515.2015.1135279. Epub 2016 Feb 2. Hum Vaccin Immunother. 2016. PMID: 26835890 Free PMC article.
-
Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.EBioMedicine. 2015 Aug 8;2(10):1494-9. doi: 10.1016/j.ebiom.2015.08.017. eCollection 2015 Oct. EBioMedicine. 2015. PMID: 26629544 Free PMC article.
-
Breaking the cycle: considerations for a life-course vaccination strategy against varicella-zoster virus.Expert Rev Vaccines. 2025 Dec;24(1):556-569. doi: 10.1080/14760584.2025.2514527. Epub 2025 Jun 19. Expert Rev Vaccines. 2025. PMID: 40511469 Review.
-
The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.J Infect Dis. 2008 Mar 1;197 Suppl 2:S224-7. doi: 10.1086/522162. J Infect Dis. 2008. PMID: 18419401 Review.
Cited by
-
Assessing the use of antibiotics and the burden of varicella in Belgium using a retrospective GP database analysis.BMC Infect Dis. 2021 Nov 11;21(1):1150. doi: 10.1186/s12879-021-06848-4. BMC Infect Dis. 2021. PMID: 34758734 Free PMC article.
-
Healthcare resource use and costs of varicella and its complications: A systematic literature review.Hum Vaccin Immunother. 2023 Dec 15;19(3):2266225. doi: 10.1080/21645515.2023.2266225. Epub 2023 Oct 27. Hum Vaccin Immunother. 2023. PMID: 37885425 Free PMC article.
-
Herpes Zoster: A Brief Definitive Review.Cornea. 2021 Aug 1;40(8):943-949. doi: 10.1097/ICO.0000000000002754. Cornea. 2021. PMID: 34029242 Free PMC article. Review.
-
Vaccines for the Elderly and Vaccination Programs in Europe and the United States.Vaccines (Basel). 2024 May 22;12(6):566. doi: 10.3390/vaccines12060566. Vaccines (Basel). 2024. PMID: 38932295 Free PMC article. Review.
-
Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines.J Can Assoc Gastroenterol. 2021 Jul 29;4(4):e59-e71. doi: 10.1093/jcag/gwab015. eCollection 2021 Aug. J Can Assoc Gastroenterol. 2021. PMID: 34476338 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials